nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone phenpropionate—CYP19A1—Paclitaxel—ovarian cancer	0.457	1	CbGbCtD
Nandrolone phenpropionate—CYP19A1—follicular fluid—ovarian cancer	0.125	0.346	CbGeAlD
Nandrolone phenpropionate—CYP19A1—corpus luteum—ovarian cancer	0.0719	0.2	CbGeAlD
Nandrolone phenpropionate—CYP19A1—ovarian follicle—ovarian cancer	0.0563	0.156	CbGeAlD
Nandrolone phenpropionate—AR—oviduct—ovarian cancer	0.0219	0.0607	CbGeAlD
Nandrolone phenpropionate—AR—Regulation of Androgen receptor activity—SPDEF—ovarian cancer	0.0102	0.0642	CbGpPWpGaD
Nandrolone phenpropionate—AR—myometrium—ovarian cancer	0.007	0.0194	CbGeAlD
Nandrolone phenpropionate—AR—Nuclear Receptors—NR5A1—ovarian cancer	0.00611	0.0385	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Ovarian Infertility Genes—NR5A1—ovarian cancer	0.00603	0.038	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Ovarian Infertility Genes—INHA—ovarian cancer	0.00587	0.0369	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—endometrium—ovarian cancer	0.00557	0.0154	CbGeAlD
Nandrolone phenpropionate—AR—epithelium—ovarian cancer	0.00549	0.0153	CbGeAlD
Nandrolone phenpropionate—AR—uterine cervix—ovarian cancer	0.00545	0.0151	CbGeAlD
Nandrolone phenpropionate—AR—decidua—ovarian cancer	0.00519	0.0144	CbGeAlD
Nandrolone phenpropionate—CYP19A1—gonad—ovarian cancer	0.00516	0.0143	CbGeAlD
Nandrolone phenpropionate—CYP19A1—uterus—ovarian cancer	0.00513	0.0142	CbGeAlD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—AREG—ovarian cancer	0.00496	0.0313	CbGpPWpGaD
Nandrolone phenpropionate—AR—endometrium—ovarian cancer	0.00493	0.0137	CbGeAlD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—NR5A1—ovarian cancer	0.00483	0.0304	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—female reproductive system—ovarian cancer	0.00461	0.0128	CbGeAlD
Nandrolone phenpropionate—AR—gonad—ovarian cancer	0.00457	0.0127	CbGeAlD
Nandrolone phenpropionate—AR—uterus—ovarian cancer	0.00454	0.0126	CbGeAlD
Nandrolone phenpropionate—CYP19A1—female gonad—ovarian cancer	0.0042	0.0116	CbGeAlD
Nandrolone phenpropionate—AR—female reproductive system—ovarian cancer	0.00408	0.0113	CbGeAlD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—BCL9—ovarian cancer	0.00385	0.0243	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—testis—ovarian cancer	0.00372	0.0103	CbGeAlD
Nandrolone phenpropionate—AR—female gonad—ovarian cancer	0.00371	0.0103	CbGeAlD
Nandrolone phenpropionate—AR—vagina—ovarian cancer	0.00369	0.0102	CbGeAlD
Nandrolone phenpropionate—CYP19A1—Endogenous sterols—CYP1B1—ovarian cancer	0.00332	0.0209	CbGpPWpGaD
Nandrolone phenpropionate—AR—testis—ovarian cancer	0.00329	0.00914	CbGeAlD
Nandrolone phenpropionate—Ethynodiol—PGR—ovarian cancer	0.00318	0.133	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Ovarian Infertility Genes—MLH1—ovarian cancer	0.00317	0.02	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptors—PGR—ovarian cancer	0.00304	0.0192	CbGpPWpGaD
Nandrolone phenpropionate—Norelgestromin—PGR—ovarian cancer	0.00301	0.126	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Ovarian Infertility Genes—PGR—ovarian cancer	0.003	0.0189	CbGpPWpGaD
Nandrolone phenpropionate—Norgestimate—PGR—ovarian cancer	0.00271	0.113	CrCbGaD
Nandrolone phenpropionate—CYP19A1—lymph node—ovarian cancer	0.0027	0.00749	CbGeAlD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—PGR—ovarian cancer	0.0024	0.0151	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Ovarian Infertility Genes—CCND2—ovarian cancer	0.0024	0.0151	CbGpPWpGaD
Nandrolone phenpropionate—AR—lymph node—ovarian cancer	0.00239	0.00663	CbGeAlD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—PARP1—ovarian cancer	0.00239	0.015	CbGpPWpGaD
Nandrolone phenpropionate—Etonogestrel—PGR—ovarian cancer	0.00234	0.0978	CrCbGaD
Nandrolone phenpropionate—AR—FOXA1 transcription factor network—BRCA1—ovarian cancer	0.00216	0.0136	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—BARD1—ovarian cancer	0.00215	0.0136	CbGpPWpGaD
Nandrolone phenpropionate—AR—FOXA1 transcription factor network—SOD1—ovarian cancer	0.00205	0.0129	CbGpPWpGaD
Nandrolone phenpropionate—Ethynodiol—ESR1—ovarian cancer	0.00201	0.0839	CrCbGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CD82—ovarian cancer	0.002	0.0126	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—ATF3—ovarian cancer	0.00193	0.0121	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Tryptophan metabolism—CYP1B1—ovarian cancer	0.00191	0.012	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—BARD1—ovarian cancer	0.00185	0.0117	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—SMARCA4—ovarian cancer	0.00183	0.0115	CbGpPWpGaD
Nandrolone phenpropionate—Norgestimate—ESR1—ovarian cancer	0.00171	0.0714	CrCbGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—BRCA1—ovarian cancer	0.00166	0.0105	CbGpPWpGaD
Nandrolone phenpropionate—Levonorgestrel—PGR—ovarian cancer	0.00166	0.0692	CrCbGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TOP1—ovarian cancer	0.00163	0.0103	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptors—ESR1—ovarian cancer	0.00162	0.0102	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.00154	0.00973	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.00152	0.0096	CbGpPWpGaD
Nandrolone phenpropionate—Etonogestrel—ESR1—ovarian cancer	0.00148	0.0617	CrCbGaD
Nandrolone phenpropionate—AR—FOXA1 transcription factor network—ESR1—ovarian cancer	0.00144	0.0091	CbGpPWpGaD
Nandrolone phenpropionate—Norethindrone—PGR—ovarian cancer	0.00134	0.0561	CrCbGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND2—ovarian cancer	0.00134	0.00844	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—MTOR—ovarian cancer	0.00133	0.00838	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—ESR1—ovarian cancer	0.00128	0.00808	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.00125	0.00788	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—BRCA1—ovarian cancer	0.00123	0.00775	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—MSH2—ovarian cancer	0.00118	0.00743	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—SMARCA4—ovarian cancer	0.0011	0.00695	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Ovarian Infertility Genes—CDKN1B—ovarian cancer	0.00109	0.00686	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—CCNE1—ovarian cancer	0.00108	0.00679	CbGpPWpGaD
Nandrolone phenpropionate—Levonorgestrel—ESR1—ovarian cancer	0.00105	0.0437	CrCbGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—MAPK3—ovarian cancer	0.00102	0.00644	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—MSH2—ovarian cancer	0.00102	0.0064	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—ovarian cancer	0.001	0.00633	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—MAPK3—ovarian cancer	0.000982	0.00619	CbGpPWpGaD
Nandrolone phenpropionate—AR—FOXA1 transcription factor network—CDKN1B—ovarian cancer	0.000982	0.00618	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—MAPK1—ovarian cancer	0.000972	0.00613	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—SMARCA4—ovarian cancer	0.000949	0.00598	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—GADD45A—ovarian cancer	0.000942	0.00593	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—MAPK1—ovarian cancer	0.000935	0.00589	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—CDKN1B—ovarian cancer	0.000931	0.00587	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—ovarian cancer	0.000886	0.00558	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CHEK2—ovarian cancer	0.00086	0.00542	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—CAV1—ovarian cancer	0.000853	0.00537	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—ovarian cancer	0.000846	0.00533	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—PIK3CA—ovarian cancer	0.000844	0.00532	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—NR5A1—ovarian cancer	0.000834	0.00525	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—GADD45A—ovarian cancer	0.00081	0.0051	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—BRCA1—ovarian cancer	0.000806	0.00508	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—PGR—ovarian cancer	0.000782	0.0327	CrCbGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—HRAS—ovarian cancer	0.000781	0.00492	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	0.00078	0.00491	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—ovarian cancer	0.000779	0.00491	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—STAT3—ovarian cancer	0.000767	0.00483	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—ovarian cancer	0.00075	0.00472	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CHEK2—ovarian cancer	0.00074	0.00466	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—CYP1B1—ovarian cancer	0.000731	0.0305	CrCbGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—BRCA2—ovarian cancer	0.000729	0.00459	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—CCND1—ovarian cancer	0.000721	0.00454	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—CTNNB1—ovarian cancer	0.000714	0.0045	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	0.000713	0.00449	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—BRCA1—ovarian cancer	0.000694	0.00437	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone—CYP1B1—ovarian cancer	0.000691	0.0289	CrCbGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—AKT1—ovarian cancer	0.000689	0.00434	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	0.000668	0.00421	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—CYP1B1—ovarian cancer	0.000665	0.00419	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—AKT1—ovarian cancer	0.000662	0.00417	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000656	0.00413	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—ovarian cancer	0.000627	0.00395	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—ovarian cancer	0.000623	0.00393	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	0.000604	0.00381	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	0.000585	0.00369	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	0.000585	0.00369	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—ovarian cancer	0.00058	0.00366	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—ovarian cancer	0.000575	0.00362	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	0.000575	0.00362	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—ovarian cancer	0.000564	0.00355	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—WDR77—ovarian cancer	0.000563	0.00355	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—ESR1—ovarian cancer	0.000538	0.00339	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—CCND1—ovarian cancer	0.000533	0.00336	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—CTNNB1—ovarian cancer	0.000528	0.00333	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—PTEN—ovarian cancer	0.000514	0.00324	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000513	0.00323	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—ESR1—ovarian cancer	0.000494	0.0206	CrCbGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—YAP1—ovarian cancer	0.000475	0.00299	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CDH1—ovarian cancer	0.000468	0.00295	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—ovarian cancer	0.000466	0.00293	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—ESR1—ovarian cancer	0.000463	0.00292	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—ovarian cancer	0.000461	0.0029	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—STAT3—ovarian cancer	0.00046	0.0029	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	0.000446	0.00281	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—TTF1—ovarian cancer	0.000442	0.00278	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	0.000422	0.00266	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—EGFR—ovarian cancer	0.000418	0.00263	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—PGR—ovarian cancer	0.000415	0.00262	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—NME2—ovarian cancer	0.000405	0.00255	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CDH1—ovarian cancer	0.000403	0.00254	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—NR5A1—ovarian cancer	0.000401	0.00253	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—AKT1—ovarian cancer	0.000401	0.00253	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—MTOR—ovarian cancer	0.00039	0.00246	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—PARP1—ovarian cancer	0.000386	0.00243	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.000365	0.0023	CbGpPWpGaD
Nandrolone phenpropionate—Norethindrone—ABCB1—ovarian cancer	0.00036	0.015	CrCbGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CASP3—ovarian cancer	0.000359	0.00226	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CASP3—ovarian cancer	0.00035	0.0022	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CCND1—ovarian cancer	0.000349	0.0022	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CTNNB1—ovarian cancer	0.000346	0.00218	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000344	0.00217	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—PTEN—ovarian cancer	0.000337	0.00212	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.000337	0.00212	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—MTOR—ovarian cancer	0.000336	0.00211	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	0.000328	0.00206	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—ovarian cancer	0.00032	0.00201	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—ovarian cancer	0.000309	0.00194	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—VEGFA—ovarian cancer	0.000304	0.00192	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	0.000303	0.00191	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—ovarian cancer	0.0003	0.00189	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—ovarian cancer	0.000298	0.00187	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	0.000297	0.00187	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.000297	0.00187	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—AKT1—ovarian cancer	0.000296	0.00187	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—ovarian cancer	0.00029	0.00183	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	0.000289	0.00182	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	0.000287	0.00181	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.00028	0.00177	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—MYC—ovarian cancer	0.00028	0.00176	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	0.000279	0.00176	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—MAPK1—ovarian cancer	0.000274	0.00173	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—EGFR—ovarian cancer	0.000274	0.00173	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—ovarian cancer	0.000262	0.00165	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYTB—ovarian cancer	0.000261	0.00165	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—KRAS—ovarian cancer	0.000259	0.00163	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000255	0.00161	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	0.000252	0.00159	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—MYC—ovarian cancer	0.000241	0.00152	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	0.000239	0.0015	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—ovarian cancer	0.000236	0.00149	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—ovarian cancer	0.000236	0.00149	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	0.000232	0.00146	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—TP53—ovarian cancer	0.00023	0.00145	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—YAP1—ovarian cancer	0.000229	0.00144	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—BRIP1—ovarian cancer	0.000228	0.00144	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PPP1CC—ovarian cancer	0.000228	0.00144	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	0.000227	0.00143	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	0.000227	0.00143	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—ovarian cancer	0.000223	0.0014	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—ESR1—ovarian cancer	0.000222	0.0014	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	0.000214	0.00135	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—ABCB1—ovarian cancer	0.00021	0.00876	CrCbGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—IL6—ovarian cancer	0.000205	0.00129	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—PGR—ovarian cancer	0.0002	0.00126	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone—ABCB1—ovarian cancer	0.000198	0.00828	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—TP53—ovarian cancer	0.000198	0.00125	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	0.000197	0.00124	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	0.000194	0.00122	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	0.000191	0.0012	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—PARP1—ovarian cancer	0.000186	0.00117	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	0.000167	0.00105	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000166	0.00105	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	0.000161	0.00101	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—YAP1—ovarian cancer	0.000153	0.000965	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000152	0.000955	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—PPP2R1A—ovarian cancer	0.000151	0.000949	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000133	0.000839	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—FASN—ovarian cancer	0.000125	0.000786	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SLC5A5—ovarian cancer	0.000123	0.000774	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SLC2A1—ovarian cancer	0.000119	0.000747	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000116	0.000732	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—MYC—ovarian cancer	0.000115	0.000726	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP1B1—ovarian cancer	0.000114	0.000716	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—ESR1—ovarian cancer	0.000107	0.000672	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PPP2R1A—ovarian cancer	0.000101	0.000635	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.0001	0.000632	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ABCB1—ovarian cancer	9.36e-05	0.00059	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—TYMS—ovarian cancer	9.2e-05	0.000579	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CAV1—ovarian cancer	7.41e-05	0.000467	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.08e-05	0.000446	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PIK3CG—ovarian cancer	6.75e-05	0.000425	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PIK3CD—ovarian cancer	5.93e-05	0.000374	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—MAPK3—ovarian cancer	5.71e-05	0.00036	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—MYC—ovarian cancer	5.55e-05	0.00035	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PIK3CB—ovarian cancer	5.17e-05	0.000326	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PTEN—ovarian cancer	4.47e-05	0.000282	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—AKT1—ovarian cancer	3.85e-05	0.000242	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PIK3CA—ovarian cancer	3.15e-05	0.000199	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—AKT1—ovarian cancer	2.58e-05	0.000162	CbGpPWpGaD
